» Articles » PMID: 37483322

Benefits of a 12-Week Non-Drug "Brain Fitness Program" for Patients with Attention-Deficit/Hyperactive Disorder, Post-Concussion Syndrome, or Memory Loss

Overview
Publisher IOS Press
Date 2023 Jul 24
PMID 37483322
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-pharmacologic interventions can potentially improve cognitive function, sleep, and/or mood in patients with attention-deficit/hyperactive disorder (ADHD), post-concussion syndrome (PCS), or memory loss.

Objective: We evaluated the benefits of a brain rehabilitation program in an outpatient neurology practice that consists of targeted cognitive training, lifestyle coaching, and electroencephalography (EEG)-based neurofeedback, twice weekly (90 minutes each), for 12 weeks.

Methods: 223 child and adult patients were included: 71 patients with ADHD, 88 with PCS, and 64 with memory loss (mild cognitive impairment or subjective cognitive decline). Patients underwent a complete neurocognitive evaluation, including tests for Verbal Memory, Complex Attention, Processing Speed, Executive Functioning, and Neurocognition Index. They completed questionnaires about sleep, mood, diet, exercise, anxiety levels, and depression-as well as underwent quantitative EEG-at the beginning and the end of the program.

Results: Pre-post test score comparison demonstrated that all patient subgroups experienced statistically significant improvements on most measures, especially the PCS subgroup, which experienced significant score improvement on all measures tested (≤0.0011; ≥0.36). After completing the program, 60% to 90% of patients scored higher on cognitive tests and reported having fewer cognitive and emotional symptoms. The largest effect size for pre-post score change was improved executive functioning in all subgroups (ADHD = 0.86; PCS = 0.83; memory = 1.09).

Conclusion: This study demonstrates that a multimodal brain rehabilitation program can have benefits for patients with ADHD, PCS, or memory loss and supports further clinical trials in this field.

References
1.
Mayes S, Calhoun S, Bixler E, Vgontzas A, Mahr F, Hillwig-Garcia J . ADHD subtypes and comorbid anxiety, depression, and oppositional-defiant disorder: differences in sleep problems. J Pediatr Psychol. 2008; 34(3):328-37. PMC: 2722128. DOI: 10.1093/jpepsy/jsn083. View

2.
Lam B, Masellis M, Freedman M, Stuss D, Black S . Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res Ther. 2013; 5(1):1. PMC: 3580331. DOI: 10.1186/alzrt155. View

3.
Nunez-Jaramillo L, Herrera-Solis A, Herrera-Morales W . ADHD: Reviewing the Causes and Evaluating Solutions. J Pers Med. 2021; 11(3). PMC: 7999417. DOI: 10.3390/jpm11030166. View

4.
Surmeli T, Eralp E, Mustafazade I, Kos I, Ozer G, Surmeli O . Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Postconcussion Syndrome (PCS): Forty Cases. How Is Neurometric Analysis Important for the Treatment of PCS and as a Biomarker?. Clin EEG Neurosci. 2016; 48(3):217-230. DOI: 10.1177/1550059416654849. View

5.
Cernich A, Kurtz S, Mordecai K, Ryan P . Cognitive rehabilitation in traumatic brain injury. Curr Treat Options Neurol. 2010; 12(5):412-23. DOI: 10.1007/s11940-010-0085-6. View